Whole-genome sequencing may not be quite ready for prime time, at least not if prime time means being widely used to test for genetic disease genes in clinical medicine, according to the results of a trial published yesterday in the Journal of the American Medical Association.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Foods You Eat

This Week in Science

What Does It Mean?

The Pair of Them

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.